论文部分内容阅读
作者于60名中期妊娠病人中观察了肌肉注射新的前列腺素(PG)类似物16-phenoxy-ω17,18,19,20四缺PGE_2(16-phenoxy E_2)中断妊娠的效能及其副作用。病人年龄从16～44岁,妊娠从14～24周。其中30名为未产妇,余为1～6胎的经产妇。所用16-phenoxy E_2是密封于安瓿中的灭菌冻于粉末(-40℃保存)。肌注前将该药1毫克溶于1毫升注射水中。病人分成三组,每组20人。第一组每4小时给药0.5毫克,平均年龄为24岁,平均妊娠为19周。第二组每8小时给药1毫克,平均年龄为25.5岁,平均妊娠为18.5周。第三组每6小时
The authors observed the efficacy and side effects of intramuscular injection of a new prostaglandin (PG) analogue 16-phenoxy-ω17,18,19,20 interrupted pregnancy in 60 patients with midterm pregnancy. Patients from 16 to 44 years of age, pregnancy from 14 to 24 weeks. Of which 30 were not mothers, more than 1 to 6 mothers by the maternal. The 16-phenoxy E_2 used was sterilized frozen in powder (-40 ° C) sealed in ampoules. Before intramuscular injection of the drug 1 mg dissolved in 1 ml of water for injection. Patients were divided into three groups of 20 people each. The first group administered 0.5 mg every 4 hours with an average age of 24 years and an average pregnancy of 19 weeks. The second group administered 1 mg every 8 hours, with an average age of 25.5 years and an average pregnancy of 18.5 weeks. The third group every 6 hours